Trastuzumab engineered with bone-homing peptides for treating breast cancer metastasis to bone Feb. 17, 2022 No Comments
Tumor-associated HEVs predict response in melanoma patients receiving anti-PD-1/CTLA-4 combination Feb. 15, 2022 No Comments
New TLR8 agonists identified at National Institute of Pharmaceutical R&D Co. Feb. 14, 2022 No Comments
Akso and Huadong Medicine sign collaborative agreement for AB-002 in Asia Pacific region Feb. 10, 2022 No Comments
Anti-VISTA HMBD-002 antibody blocks VISTA-induced immunosuppression in preclinical models Feb. 10, 2022 No Comments
Scientists identify role of PDGF-D-PDGFR-beta signaling pathway in survival of human NK cells Feb. 9, 2022 No Comments
Novel PSCA CAR_s15 NK cell immunotherapy prolongs survival in pancreatic cancer model Feb. 8, 2022 No Comments
RSS